Grace Therapeutics reported net income of -$15.79M for the quarter ended Jun 2026. This income statement covers 32 quarters of results from Feb 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Feb2017 | Mar2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 5.46M | 7.38M | 6.14M | 7.42M | 7.44M | 7.44M | 7.44M | 7.44M | 7.55M | 9.40M | 9.40M | 10.14M | 10.14M | 10.14M | 13.72M | 13.83M | 14.13M | 15.47M | 16.02M | 16.27M | ||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||||||||
| Gross Profit | ||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.58M | 2.18M | 2.33M | 2.59M | 3.29M | 2.45M | 1.64M | 1.09M | 0.46M | 1.44M | 1.69M | 2.71M | 2.98M | 2.19M | 1.63M | 0.95M | 0.57M | 0.46M | 0.42M | 0.70M | ||||||||||||
| Wages, Salaries and OtherWages | 1.49M | 0.98M | 0.65M | 0.61M | 0.99M | 1.10M | 0.87M | 1.55M | 0.90M | |||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 2.96M | 1.81M | 1.82M | 1.92M | 1.68M | 1.59M | 2.43M | 1.87M | 1.63M | 1.60M | 1.58M | 2.25M | 1.85M | 1.51M | 1.55M | 2.13M | 1.96M | 1.99M | 2.59M | 1.69M | ||||||||||||
| Restructuring CostsRestructuring | 1.49M | |||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 3.54M | 3.99M | 4.15M | 4.51M | 4.97M | 4.04M | 4.07M | 4.45M | 2.09M | 3.04M | 3.26M | 4.96M | 4.83M | 3.70M | 3.18M | 3.09M | 2.53M | 2.45M | 3.01M | 2.38M | ||||||||||||
| Operating IncomeOp. Inc | -3.57M | -4.47M | -4.40M | -4.73M | -5.11M | -4.25M | -38.07M | -4.45M | -2.09M | -3.04M | -3.26M | -4.96M | -4.83M | -3.70M | -3.18M | -3.09M | -2.53M | -2.45M | -3.01M | -15.92M | ||||||||||||
| EBIT | -3.57M | -4.47M | -4.40M | -4.73M | -5.11M | -4.25M | -38.07M | -4.45M | -2.09M | -3.04M | -3.26M | -4.96M | -4.83M | -3.70M | -3.18M | -3.09M | -2.53M | -2.45M | -3.01M | -15.92M | ||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | ||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.04M | 0.03M | 0.04M | 0.07M | 0.11M | 0.13M | 0.21M | 0.32M | 0.25M | 0.23M | 0.17M | 0.14M | 0.17M | 0.20M | 0.17M | 0.17M | 0.14M | 0.14M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 1.10M | -0.17M | -0.25M | -0.08M | -0.01M | -0.01M | -1.24M | 0.01M | -0.01M | 0.00M | -0.54M | -0.01M | 0.01M | -0.02M | 0.48M | 0.01M | -0.01M | 0.00M | -0.00M | -0.01M | ||||||||||||
| Non Operating IncomeNon Op. Inc. | 4.55M | 0.70M | -0.15M | -0.04M | 0.02M | 0.08M | 0.12M | 0.14M | -1.63M | 0.44M | -0.79M | 1.62M | 0.55M | -1.06M | 2.80M | -0.27M | 1.59M | 0.13M | 0.13M | 0.13M | ||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||
| EBT | 0.98M | -3.78M | -4.55M | -4.77M | -5.08M | -4.16M | -37.96M | -4.31M | -3.72M | -2.60M | -4.05M | -3.34M | -4.28M | -4.76M | -0.38M | -3.36M | -0.94M | -2.31M | -2.88M | -15.79M | ||||||||||||
| Tax ProvisionsTaxes | -2.77M | -0.24M | -0.15M | -0.27M | -13.10M | -0.29M | -0.45M | -0.21M | -2.14M | -0.72M | -0.85M | -0.60M | -1.02M | -1.99M | ||||||||||||||||||
| Profit After TaxPAT | 0.98M | -3.78M | -7.82M | -4.52M | -4.93M | -3.89M | -29.09M | -4.02M | -3.27M | -2.39M | -3.17M | -2.62M | -3.43M | -4.16M | 0.64M | -3.36M | -0.94M | -2.31M | -1.18M | -15.79M | ||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.98M | -3.78M | -1.78M | -4.52M | -4.93M | -3.89M | -24.86M | -4.02M | -3.27M | -2.39M | -1.91M | -2.62M | -3.43M | -4.16M | 0.64M | -3.36M | -0.94M | -2.31M | -0.89M | -15.79M | ||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.98M | -3.78M | -1.78M | -4.52M | -4.93M | -3.89M | -24.86M | -4.02M | -3.27M | -2.39M | -1.91M | -2.62M | -3.43M | -4.16M | 0.64M | -3.36M | -0.94M | -2.31M | -0.89M | -15.79M | ||||||||||||
| Income towards Parent CompanyParent Net Inc | 0.98M | -3.78M | -1.78M | -4.52M | -4.93M | -3.89M | -24.86M | -4.02M | -3.27M | -2.39M | -1.91M | -2.62M | -3.43M | -4.16M | 0.64M | -3.36M | -0.94M | -2.31M | -0.89M | -15.79M | ||||||||||||
| Net Income towards Common StockholdersNet Income | 0.98M | -3.78M | -1.78M | -4.52M | -4.93M | -3.89M | -24.86M | -4.02M | -3.27M | -2.39M | -1.91M | -2.62M | -3.43M | -4.16M | 0.64M | -3.36M | -0.94M | -2.31M | -0.89M | -15.79M | ||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.18 | -0.51 | -0.29 | -0.61 | -0.66 | -0.52 | -3.34 | -0.54 | -0.43 | -0.21 | -0.20 | -0.24 | -0.30 | -0.36 | 0.05 | -0.21 | -0.06 | -0.14 | -0.05 | -0.91 | ||||||||||||
| EPS (Diluted) | 0.18 | -0.51 | -0.29 | -0.61 | -0.66 | -0.52 | -3.34 | -0.54 | -0.43 | -0.21 | -0.20 | -0.24 | -0.30 | -0.36 | 0.05 | -0.21 | -0.06 | -0.14 | -0.05 | -0.91 | ||||||||||||
| Shares Outstanding | 5.46M | 7.38M | 6.14M | 7.39M | 7.43M | 7.44M | 7.44M | 7.44M | 7.55M | 11.51M | 9.53M | 10.93M | 11.51M | 11.51M | 12.09M | 15.92M | 15.92M | 16.93M | 16.51M | 17.27M | ||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 5.46M | 7.38M | 6.14M | 7.39M | 7.43M | 7.44M | 7.44M | 7.44M | 7.55M | 11.51M | 9.53M | 10.93M | 11.51M | 11.51M | 12.09M | 15.92M | 15.92M | 16.93M | 16.51M | 17.27M | ||||||||||||
| EBITDA | -3.57M | -4.47M | -4.40M | -4.73M | -5.11M | -4.25M | -38.07M | -4.45M | -2.09M | -3.04M | -3.26M | -4.96M | -4.83M | -3.70M | -3.18M | -3.09M | -2.53M | -2.45M | -3.01M | -15.92M | ||||||||||||
| Interest ExpensesInt Expense | ||||||||||||||||||||||||||||||||
| Tax Rate | 60.94 | 5.08 | 3.05 | 6.58 | 34.51 | 6.70 | 11.99 | 8.00 | 52.80 | 21.67 | 19.89 | 12.71 | 266.49 | 69.25 |